Citius Pharmaceuticals, Inc. (CTXR) Misses Q3 EPS by 1c

Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) reported Q3 EPS of ($0.06), $0.01 worse than the analyst estimate of ($0.05).

For earnings history and earnings-related data on Citius Pharmaceuticals, Inc. (CTXR) click here.

You May Also Be Interested In

• Costco (COST) Tops Q4 EPS by 20c
• Utah Medical Products launches tender offer for shares at $75 each
• Encompass Health plans two hospitals in Montgomery County, Texas